References
- AC Pande, DE Feltner, JW Jefferson, JR Davidson, M Pollack, MB Stein, RB Lydiard, R Futterer, P Robinson, M Slomkowski, E DuBoff, M Phelps, CA Janney, and JL Werth. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol 2004; 24:141–149.
- AJ Braga, and K Chidley. Self-poisoning with lamotragine and pregabalin. Anaesthesia 2007; 62524–547.
- E Ben-Menachem. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004; 4513–18.
- EJ Randinitis, EL Posvar, CW Alvey, AJ Sedman, JA Cook, and HN Bockbrader. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 2003; 43:277–283.
- D Berry, and C Millington. Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC. Ther Drug Monit 2005; 27451–456.
- Lyrica® (pregabalin) [package insert]New York, NY: Pfizer Inc., 2005.